News

Two simple biomarkers could differentiate which young women with ER+ breast cancer need chemotherapy

By 65 views
0
Glass laboratory flasks on light table

New research from Yale Cancer Center identified that two simple biomarkers, immune cells and estrogen receptor levels, could differentiate which young women with ER+ breast cancer need chemotherapy to improve their survival, and which only need a monthly injection to suppress ovarian function.

Feeling poorer than your friends in early adolescence is associated with worse mental health, study finds

Previous article

CLIMB method offers a more efficient way to uncover biologically meaningful changes in genomic data

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News